A detailed history of Sargent Bickham Lagudis LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 16,520 shares of JNJ stock, worth $2.56 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
16,520
Previous 16,129 2.42%
Holding current value
$2.56 Million
Previous $2.64 Million 10.74%
% of portfolio
0.24%
Previous 0.24%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023

BUY
$160.2 - $179.79 $62,638 - $70,297
391 Added 2.42%
16,520 $0
Q3 2022

Oct 27, 2022

SELL
$161.33 - $179.52 $32,588 - $36,263
-202 Reduced 1.24%
16,129 $2.64 Million
Q2 2022

Jul 13, 2022

SELL
$168.19 - $186.01 $23,378 - $25,855
-139 Reduced 0.84%
16,331 $2.9 Million
Q1 2022

Apr 27, 2022

SELL
$158.14 - $179.59 $1.21 Million - $1.37 Million
-7,634 Reduced 31.67%
16,470 $2.92 Million
Q4 2021

Jan 18, 2022

SELL
$155.93 - $173.01 $22,921 - $25,432
-147 Reduced 0.61%
24,104 $4.12 Million
Q3 2021

Nov 05, 2021

BUY
$161.5 - $179.47 $135,660 - $150,754
840 Added 3.59%
24,251 $3.92 Million
Q2 2021

Jul 19, 2021

BUY
$159.48 - $171.07 $56,774 - $60,900
356 Added 1.54%
23,411 $3.86 Million
Q1 2021

May 24, 2021

BUY
$153.07 - $170.48 $54,645 - $60,861
357 Added 1.57%
23,055 $3.79 Million
Q4 2020

May 24, 2021

SELL
$137.11 - $157.38 $48,948 - $56,184
-357 Reduced 1.55%
22,698 $3.57 Million
Q4 2020

May 24, 2021

BUY
$137.11 - $157.38 $734,498 - $843,084
5,357 Added 30.27%
23,055 $3.79 Million
Q3 2020

Sep 01, 2021

BUY
$140.38 - $153.83 $180,247 - $197,517
1,284 Added 7.82%
17,698 $2.64 Million
Q2 2020

Sep 07, 2021

BUY
$128.81 - $155.51 $19,192 - $23,170
149 Added 0.92%
16,414 $2.31 Million
Q1 2020

Sep 07, 2021

BUY
$111.14 - $153.99 $342,866 - $475,059
3,085 Added 23.41%
16,265 $2.13 Million
Q4 2019

Sep 14, 2021

BUY
$127.5 - $146.44 $2,167 - $2,489
17 Added 0.13%
13,180 $1.92 Million
Q3 2019

Sep 14, 2021

BUY
$126.95 - $142.14 $124,411 - $139,297
980 Added 8.04%
13,163 $1.7 Million
Q2 2019

Sep 13, 2021

BUY
$131.15 - $144.24 $70,165 - $77,168
535 Added 4.59%
12,183 $1.7 Million
Q1 2019

Sep 13, 2021

BUY
$125.72 - $139.79 $67,763 - $75,346
539 Added 4.85%
11,648 $1.63 Million
Q4 2018

Sep 13, 2021

BUY
$122.84 - $147.84 $73,212 - $88,112
596 Added 5.67%
11,109 $1.43 Million
Q3 2018

Sep 13, 2021

SELL
$121.58 - $142.88 $20,668 - $24,289
-170 Reduced 1.59%
10,513 $1.45 Million
Q2 2018

Sep 13, 2021

BUY
$119.4 - $131.76 $26,029 - $28,723
218 Added 2.08%
10,683 $1.3 Million
Q1 2018

Sep 13, 2021

SELL
$125.1 - $148.14 $92,574 - $109,623
-740 Reduced 6.6%
10,465 $1.34 Million
Q4 2017

Sep 13, 2021

SELL
$131.22 - $143.62 $85,161 - $93,209
-649 Reduced 5.47%
11,205 $1.57 Million
Q3 2017

Sep 13, 2021

SELL
$129.47 - $135.38 $86,356 - $90,298
-667 Reduced 5.33%
11,854 $1.54 Million
Q2 2017

Sep 13, 2021

BUY
N/A
611 Added 5.13%
12,521 $1.66 Million
Q1 2017

Sep 13, 2021

SELL
N/A
-402 Reduced 3.27%
11,910 $1.48 Million
Q4 2016

Sep 13, 2021

BUY
N/A
12,098 Added 5653.27%
12,312 $1.42 Million
Q3 2016

Sep 13, 2021

SELL
N/A
-8,565 Reduced 97.56%
214 $1.07 Million
Q2 2016

Sep 07, 2021

SELL
N/A
-12,952 Reduced 59.6%
8,779 $1.07 Million
Q1 2016

Sep 07, 2021

BUY
N/A
21,731
21,731 $2.35 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.